baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Ionis Pharmaceuticals Inc/ US4622221004 /

2024-08-28 10:00:00 PM	Chg. +0.9000	Volume	Bid10:00:10 PM	Ask10:00:10 PM	High	Low
49.2500USD	+1.86%	940,035 Turnover: 28.75 mill.	44.1000Bid Size: 100	50.0000Ask Size: 100	49.4900	47.8625

GlobeNewswire 08-13 Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...

Newsfile Corp 07-17 Analysts Hunt for Undervalued Biotech Stocks

GlobeNewswire 05-30 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...

GlobeNewswire 05-16 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...

GlobeNewswire 05-13 Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Result...

GlobeNewswire 05-07 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference

GlobeNewswire 04-23 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held M...

GlobeNewswire 04-22 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...

GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...

GlobeNewswire 03-05 Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...

GlobeNewswire 02-23 Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...

GlobeNewswire 01-08 Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio

TeleTrader 2023-12-22 US FDA approves AstraZeneca-Ionis's medicine

GlobeNewswire 2022-03-28 Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotroph...

GlobeNewswire 2022-03-17 Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors

GlobeNewswire 2022-03-14 Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference

GlobeNewswire 2022-03-09 Antisense Therapeutics to present poster at world’s largest NMD conference

GlobeNewswire 2022-02-24 ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

GlobeNewswire 2022-02-02 n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare D...

GlobeNewswire 2022-01-04 Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA

GlobeNewswire 2022-01-03 Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer

GlobeNewswire 2021-12-10 Cytokinetics Announces Data From Its ALS Program Presented at the 32nd International Symposium on AL...

GlobeNewswire 2021-11-18 ProQR Announces Highlights from Analyst Event

GlobeNewswire 2021-11-15 CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors

GlobeNewswire 2021-11-04 ProQR Announces Third Quarter 2021 Operating and Financial Results

Ionis Pharmaceuticals Inc/ US4622221004 /

If you wish to receive reply to your feedback, please provide your email address.